Bio Marin Pharmaceutical Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Bio Marin Pharmaceutical is a biotechnology company headquartered in Novato, California, focused on research and development in the rare-disease field. In 2026 it advanced its pipeline with BMN 333, a drug candidate planned to enter a phase 2/3 program in the first half of the year. The company also pursues external collaborations to accelerate rare-disease discovery and development, including a March 2026 partnership with Genomics Ltd. 

Its global footprint in the rare-disease market is reflected by product sales in 72 countries. Early 2026 saw leadership changes, including the appointment of Arpit Davé as Executive Vice President and Chief Digital and Information Officer.

Sign up for free to view info

Company overview Employee directory